2 line items for nicotine mini lozenges 36E79721D0038. Awarded for a base year and 4 one-year option periods. 7/19/2021 - 7/18/2022 for the base year.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0038
- Awardee
-
The Harvard Drug Group, L.L.C. UEI CBGGKKVNJBK9 Part of Cardinal Health, Inc.
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Nicotine Lozenges MINI Pre-Solicitation · 36E79721R0024 · Posted Mar 25, 2021
- 6505--Nicotine Lozenges MINI Award Notice · Posted Jul 29, 2021
- 6505--Nicotine Lozenges MINI Solicitation · Posted Apr 2, 2021
- Last date to order 100% complete
- IDV ceiling
- $11,739,339.15
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded an indefinite-delivery contract to The Harvard Drug Group, L.L.C., a single award with a ceiling value of $11,739,339.15 on July 19, 2021. The contract carries no set-aside and covers two line items for nicotine mini lozenges under a base year plus four one-year option periods, with the base year running from July 19, 2021 through July 18, 2022. The contract ultimately completes on July 18, 2026.
The Harvard Drug Group is a Native Hawaiian Organization-owned subsidiary of Cardinal Health, Inc., headquartered in La Vergne, Tennessee, and operates as a pharmaceutical distributor and manufacturer through its Major Pharmaceuticals & Rugby Laboratories division under the trade name First Veterinary Supply. The source identifies The Harvard Drug Group as a critical vendor supplying over-the-counter and pharmaceutical products to federal healthcare infrastructure, including military, veterans affairs, and civilian medical supply chains.
Place of performance is La Vergne, Tennessee. The originating solicitation was posted as a pre-solicitation notice on March 25, 2021, with a due date of April 14, 2021, and resulted in award on July 19, 2021. The contract is funded by the National Acquisition Center, a civilian federal agency.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor Address Change | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract 36E79721D0038?
36E79721D0038 was awarded to The Harvard Drug Group, L.L.C. by National Acquisition Center (Headquarters) on July 19, 2021.
How much is contract 36E79721D0038 worth?
36E79721D0038's own ceiling is $11,739,339.
Who can order from contract 36E79721D0038?
36E79721D0038 is a single award indefinite delivery contract.
Was contract 36E79721D0038 competed?
The extent of competition for 36E79721D0038 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV